logo
Pharma-driven Irish GDP growth revised down to 7.4% q/q in Q1

Pharma-driven Irish GDP growth revised down to 7.4% q/q in Q1

Reuters08-07-2025
DUBLIN, July 8 (Reuters) - Rapid growth in Ireland's gross domestic product (GDP) during the first three months of the year was revised down on Tuesday to 7.4% quarter-on-quarter from 9.7% previously.
The growth was driven by a surge in pharmaceutical exports to the U.S. ahead of threatened tariffs, officials have said.
With Ireland's large multinational sector often distorting GDP, officials prefer to use modified domestic demand (MDD) to gauge the strength of the domestic economy.
Quarter-on-quarter MDD growth was revised sharply up to 2.0% from a provisional 0.8%, Central Statistics Office (CSO) data showed.
Revisions to previous quarters meant MDD grew by a slower 1.8% in 2024 compared to the 2.7% initially reported.
GDP, which is still used to calculate Ireland's share of activity across the euro zone, grew by 2.6% in 2024 versus an initial estimate of +1.2%.
Modified gross national income (GNI*), an annual measure that also strips out the distorting impacts of multinationals to give a more accurate picture of the total size of the Irish economy, suggested it grew by 4.8% in 2024 compared to 2023.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Quiet luxury is out and that's great news for Burberry
Quiet luxury is out and that's great news for Burberry

Telegraph

time13 minutes ago

  • Telegraph

Quiet luxury is out and that's great news for Burberry

Questor is The Telegraph's stock-picking column, helping you decode the markets and offering insights on where to invest After a wild and scary ride, we are back to breakeven in our Burberry position. This gives us the option to check out of the British fashion icon without any undue portfolio damage, but it is early in the turnaround sought by chief executive Joshua Schulman. For the moment, we are inclined to give him and the company the benefit of the doubt, even if the headline financial figures do not entice at first glance. This month's first-quarter trading update was no great thing of beauty either. Comparable store sales for the three months to June fell 1pc year on year at the retail arm, and that came on top of a 21pc plunge in the equivalent period a year ago. Yet that was still better than the analysts' expectation of a 3pc decline. Moreover, it does seem as if things have stopped getting worse, and if they have stopped getting worse then at some stage they might just start getting better – especially if Mr Schulman's plans to reinvigorate the brand and product ranges come to fruition. At least 'quiet luxury' is out, according to this columnist's daughter's editions of Vogue, and a return to favour for luxury would at least provide a more encouraging backdrop, despite the uncertain macroeconomic environment. Last year's operating loss and absence of a dividend mean investors have to buy into the turnaround plan for them to be even vaguely optimistic about Burberry's share price maintaining its momentum – it is up 85pc in a year and by more than double from the autumn 2024 lows. A price-to-earnings ratio of more than 80 for the year to March 2026 and forecasts of a 6pc operating margin show just how much work the luxury goods specialist has to do after a terribly difficult two years. Analysts only expect a 12pc operating margin by March 2028, well below the 20pc-plus return on sales generated by leading plutocratic product makers such as LVMH and Richemont. A return to the 16pc level that prevailed between 2016 and 2021 would leave Burberry on 17 times 2028 earnings, and a dash to 20pc would put it on a tempting 13 times. Again, we are long way from that, but the worst may be behind Burberry and patience could yet get a reward. Questor says: Buy Genus (GNS) £24.75 We are off to a fast start with Genus and already have a paper gain of around 25pc to show for our initial analysis back in spring. This month's year-end update reads well and offers more than enough hints to suggest that our investment thesis for the genomics expert is still on the mark. The trading statement revealed that adjusted pre-tax profit for the year to June 2025 would be at least £72m, even though unhelpful foreign exchange movements cost the company some £8.4m. Of Genus' two divisions, Pig Improvement Company (PIC) continued to perform strongly, and the bovine-oriented American Breeders Service (ABS) showed some signs of improved momentum. In the latter case, things can hardly get any worse given that US cattle inventory languishes at 70-year lows. Any upturn here could bring benefits to ABS. Its expertise in genomics helps dairy farmers increase the chances of cows giving birth to female calves suitable for dairy production or young more suited to beef production. Perhaps most importantly of all, the trading statement flags the first tangible benefits of American regulatory approval from the Food and Drug Administration (FDA) for Genus' PRRS (Porcine Reproductive and Respiratory Syndrome) Pig Resistant Programme (PRP). FDA approval opens the way to the commercialisation of PRP and is already triggering milestone payments from partner companies, as evidenced by the £3.7m received from Beijing Capital Agribusiness. Such payments should help cash flow, too, and, as a result, chief executive Jorgen Kokke signals a reduction in net debt in this month's update. This is a further boost for the investment case, as Genus' record for free cash flow generation in the past few years is spotty at best. If the investment in PRRS starts to pay off, then cash flow could blossom and a reduction in debt would reduce net interest costs and provide a further kicker to profits growth. As it is, the forecast of £72m in pre-tax income for the fiscal year just ended would be a record for the FTSE 250 index member, yet the share price still stands at less than half 2021's peak, even after the recent run.

Revealed: The scale of cheap Chinese imports flown into UK without paying any tariffs
Revealed: The scale of cheap Chinese imports flown into UK without paying any tariffs

Sky News

time40 minutes ago

  • Sky News

Revealed: The scale of cheap Chinese imports flown into UK without paying any tariffs

The scale of cheap Chinese e-commerce imports flown into Britain without paying any tariffs has become clearer following a Sky News investigation into this new multi-billion pound phenomenon. We have uncovered the first official estimate of the value of so-called "de minimis" imports into Britain, ahead of an official inquiry into whether this legal clause - which excludes packages worth less than £135 from paying customs duties - should be allowed to continue. Companies like Shein and Temu have become big players in British retail, not to mention elsewhere around the world, by manufacturing cheap products in China and then posting them directly to consumers, benefiting from the de minimis rules. Clothing manufacturers in the UK claim that de minimis makes it nearly impossible to compete with these Chinese competitors, raising questions about the viability of domestic textile and apparel production. However, economists argue that the main beneficiaries of the policy to exclude cheap imports from customs are lower-income households, since it allows them to spend less on their shopping. Removing it, they say, would disproportionately affect poorer families. The government has committed to an inquiry into the rules, which are also being changed in the EU and the US, but up until now there has been no official estimate of its scale. According to HM Revenue and Customs data released to Sky News following a Freedom of Information request, the total declared trade value of de minimis imports into the UK in the last fiscal year (2024-25) was £5.9bn. That was a 53% increase on the previous year (£3.9bn), underlining the scale of growth of e-commerce imports into the UK. While it is hard to gauge how much revenue this means the Treasury has forgone, an illustrative 20% tariff on flows of that order could raise more than £1bn. While that sum alone would not fill the fiscal black hole faced by Chancellor Rachel Reeves in the coming budget, it would nonetheless be nearly enough to pay for the government's recent U-turn on winter fuel allowances. Sky has also obtained the first television access deep into the supply chain, helping bring those goods into the UK, as it boarded a flight that had just travelled from Chongqing to Bournemouth Airport. We filmed inside the belly of a plane belonging to European Cargo, one of a number of air cargo firms booming as a result of these trade flows. The untold story about de minimis is that it hasn't just had an impact on shopping habits in the UK, or for that matter, the textiles manufacturing sector - it has also changed patterns of distribution. Struggling regional airports that never saw their passenger numbers recover after the pandemic are now re-establishing themselves as hubs for cargo. European Cargo is now the single biggest airline at Bournemouth Airport, despite not carrying a single passenger. Other regional airports like East Midlands Airport and Prestwick in Scotland are seeing rapid growth in flows of trade. All of which raises the stakes for the government's inquiry into the de minimis system. At present, there is no timeline for its decision, but removing the clause would have far-reaching effects across the economy.

Swiss chemical maker Sika's half-year sales falls, misses analyst estimate
Swiss chemical maker Sika's half-year sales falls, misses analyst estimate

Reuters

time43 minutes ago

  • Reuters

Swiss chemical maker Sika's half-year sales falls, misses analyst estimate

ZURICH, July 29 (Reuters) - Sika (SIKA.S), opens new tab reported lower half-year sales and profit on Tuesday as the weaker dollar shrunk the construction chemicals maker's earnings when converted back into Swiss francs. The company, which makes products used to strengthen and waterproof walls and floors, said its sales fell 2.7% to 5.68 billion Swiss francs ($7.08 billion) in the six months to June 30. Analysts had forecast 5.72 billion francs, according to a consensus compiled by Vara. ($1 = 0.8026 Swiss francs)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store